(Q45878873)

17 December 2017

title

Effects of in vivo depletion of immunocyte populations on herpes simplex virus glycoprotein D vaccine-induced resistance to HSV2 challenge (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1319710

13 September 2022

Effects ofin VivoDepletion of Immunocyte Populations on Herpes Simplex Virus Glycoprotein D Vaccine-Induced Resistance to HSV2 Challenge (English)

1 reference

https://api.crossref.org/works/10.1089/VIM.1992.5.151

6 December 2023

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1319710

13 September 2022

1 reference

https://api.crossref.org/works/10.1089/VIM.1992.5.151

6 December 2023

1 reference

https://api.crossref.org/works/10.1089/VIM.1992.5.151

6 December 2023

author name string

E. M. Mishkin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1319710

13 September 2022

M. Blasiak

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1319710

13 September 2022

D. Giorgio

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1319710

13 September 2022

S. T. Ishizaka

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1319710

13 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1319710

13 September 2022

publication date

1 January 1992

1 reference

17 December 2017

full work available at URL

https://www.liebertpub.com/doi/pdf/10.1089/vim.1992.5.151

1 reference

https://api.crossref.org/works/10.1089/VIM.1992.5.151

6 December 2023

1 reference

17 December 2017

volume

5

1 reference

17 December 2017

issue

2

1 reference

17 December 2017

page(s)

151-161

1 reference

17 December 2017

Specificity of the immune response of mice to herpes simplex virus glycoproteins B and D constitutively expressed on L cell lines

cites work

1

1 reference

https://api.crossref.org/works/10.1089/VIM.1992.5.151

Delta 9-tetrahydrocannabinol decreases alpha/beta interferon response to herpes simplex virus type 2 in the B6C3F1 mouse.

6 December 2023

2

1 reference

https://api.crossref.org/works/10.1089/VIM.1992.5.151

A herpesvirus antigen in human premalignant and malignant cervical biopsies and explants

6 December 2023

3

1 reference

https://api.crossref.org/works/10.1089/VIM.1992.5.151

Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo

6 December 2023

4

1 reference

https://api.crossref.org/works/10.1089/VIM.1992.5.151

Type-Common CP-1 Antigen of Herpes Simplex Virus Is Associated with a 59,000-Molecular-Weight Envelope Glycoprotein

6 December 2023

5

1 reference

https://api.crossref.org/works/10.1089/VIM.1992.5.151

Acute and latent herpes simplex virus neurological disease in mice immunized with purified virus-specific glycoproteins gB or gD.

6 December 2023

6

1 reference

https://api.crossref.org/works/10.1089/VIM.1992.5.151

Effects of selective depletion of L3T4+ T-lymphocytes on herpes simplex virus encephalitis

6 December 2023

8

1 reference

https://api.crossref.org/works/10.1089/VIM.1992.5.151

Anti-glycoprotein D antibodies that permit adsorption but block infection by herpes simplex virus 1 prevent virion-cell fusion at the cell surface

6 December 2023

10

1 reference

https://api.crossref.org/works/10.1089/VIM.1992.5.151

Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration

6 December 2023

12

1 reference

https://api.crossref.org/works/10.1089/VIM.1992.5.151

Native HSV Glycoprotein D Subunit Vaccine: Analysis ofin VitroT-Cell Activation and Antigen Presentation*

6 December 2023

13

1 reference

https://api.crossref.org/works/10.1089/VIM.1992.5.151

Lysis of herpesvirus-infected cells by macrophages activated with free or liposome-encapsulated lymphokine produced by a murine T cell hybridoma

6 December 2023

15

1 reference

https://api.crossref.org/works/10.1089/VIM.1992.5.151

Cell-mediated immunity against herpes simplex induction of cytotoxic T lymphocytes

6 December 2023

17

1 reference

https://api.crossref.org/works/10.1089/VIM.1992.5.151

The causative role of herpesvirus type 2 in cervical cancer

6 December 2023

20

1 reference

https://api.crossref.org/works/10.1089/VIM.1992.5.151

Native herpes simplex virus glycoprotein D vaccine: immunogenicity and protection in animal models

6 December 2023

21

1 reference

https://api.crossref.org/works/10.1089/VIM.1992.5.151

delta-9-Tetrahydrocannabinol decreases host resistance to herpes simplex virus type 2 vaginal infection in the B6C3F1 mouse

6 December 2023

22

1 reference

https://api.crossref.org/works/10.1089/VIM.1992.5.151

Activated macrophages mediate interferon-independent inhibition of herpes simplex virus

6 December 2023

23

1 reference

https://api.crossref.org/works/10.1089/VIM.1992.5.151

Different roles for L3T4+ and Lyt 2+ T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system

6 December 2023

24

1 reference

https://api.crossref.org/works/10.1089/VIM.1992.5.151

Effect of macrophage activation on resistance of mouse peritoneal macrophages to infection with herpes simplex virus types 1 and 2.

6 December 2023

27

1 reference

https://api.crossref.org/works/10.1089/VIM.1992.5.151

Herpes simplex virus (HSV)-specific human T-cell clones recognize HSV glycoprotein D expressed by a recombinant vaccinia virus

6 December 2023

28

1 reference

https://api.crossref.org/works/10.1089/VIM.1992.5.151

Experimental Infection of Inbred Mice with Herpes Simplex Virus Type 1. I. Investigation of Humoral and Cellular Immunity and of Interferon Induction

6 December 2023

29

1 reference

https://api.crossref.org/works/10.1089/VIM.1992.5.151

6 December 2023

Identifiers

1 reference

17 December 2017

1 reference

17 December 2017